A Mississauga, Ontario-based medical marijuana company is taking steps to raise 50 million Canadian dollars ($40 million) through a private placement of its securities to expand its existing facility and pursue strategic pharmaceutical assets.

TerrAscend – traded on the Canadian Securities Exchange under the symbol TER – said in a news release that it entered into subscription agreements involving 47 million shares of the company.


Once the private placement closes, JW Asset Management will own 36.8% of TerrAscend, Canopy Growth will own 12% and Canopy Rivers will own 12%.

JW Asset Management specializes in early stage venture investments.

Canopy Rivers, a subsidiary of Canopy Growth, invests in and enters into cannabis streaming agreements with licensed producers.

What you need to know:

  • The closing of the private placement is subject to TerrAscend joining Canopy Growth’s CraftGrow program.
  • Canopy’s CraftGrow brings cannabis grown by a variety of producers to the Tweed Main Street online marketplace.
  • Each share sold in the private placement will consist of one common share and one warrant for an additional share.
To sign up for our weekly Canada marijuana business newsletter, click here.